ENTERO vs PRAVEG: Stock Comparison

Entero Healthcare Solutions Limited vs Praveg Ltd

Live data: 28 July 2026, 4:08 PM IST • Source: NSE and company filings

Entero Healthcare Solutions Limited is the larger company by market capitalisation. Entero Healthcare Solutions Limited shows a higher ROE, faster revenue growth and a higher ROCE, while Praveg Ltd shows a lower P/E, a higher dividend yield and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Entero Healthcare Solutions Limited and Praveg Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, ENTERO is more favourable on 8 of 13 scored metrics and PRAVEG on 5These counts are context-free and are not an overall rating.

Key Differences

Market Cap
ENTERO is the larger company
₹5,400 Cr vs ₹748 Cr
P/E Ratio
PRAVEG has a lower P/E
-64.78x vs 46.67x
P/B Ratio
PRAVEG has a lower P/B
1.66x vs 3.18x
EPS
ENTERO has higher earnings per share
₹26.44 vs ₹-4.41
Dividend Yield
PRAVEG has a higher dividend yield
0.43% vs 0%
Revenue Growth (TTM YoY)
ENTERO has faster revenue growth
42.6% vs 0%
EPS Growth (TTM YoY)
ENTERO has faster EPS growth
9.1% vs 0%
Qtr Sales Growth
ENTERO has stronger quarterly sales growth
42.6% vs 26.8%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricENTEROPRAVEG
SectorConsumer Services
IndustryPharmacy Retail

Price

MetricENTEROPRAVEG
Live Price₹1,235.8₹285.3
Day Change-2.95%-5.24%
Volume34,9171.28 L
52-Week High₹1,390₹325
52-Week Low₹944₹210.4
Distance from 52W High-11.09%-12.22%

Valuation

MetricENTEROPRAVEG
Market Cap₹5,400 Cr₹748 Cr
P/E Ratio46.67x-64.78x
P/B Ratio3.18x1.66x
EPS₹26.44₹-4.41
Book Value₹388.26₹172
Dividend Yield0%0.43%

Growth

MetricENTEROPRAVEG
Revenue Growth (TTM YoY)42.6%0%
EPS Growth (TTM YoY)9.1%0%
Qtr Sales Growth42.6%26.8%
Qtr Profit Growth9.03%-242%

Profitability & Leverage

MetricENTEROPRAVEG
ROE6.99%-2.51%
ROCE10.6%1.72%
Net Margin1.75%-4.14%
Operating Margin4.04%23.9%
Debt to Equity0.4x0.38x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricENTEROPRAVEG
Promoter Holding14.4% 0.01 pp46.06% 0.12 pp
FII Holding4.37% 0.34 pp2.73% 0.74 pp
DII Holding15.48% 1.14 pp4.65% 0.2 pp
Public Holding27.75% 0.82 pp46.56% 0.82 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Entero Healthcare Solutions Limited and Praveg Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.